Treatment and prevention of genital herpes
Adrian Mindel
Abstract
Adrian Mindel
Abstract
Genital herpes is one of the commonest sexually transmitted infections. Several antiviral drugs, including acyclovir, famciclovir, and valaciclovir, are now (or will soon be) available for the treatment of genital herpes. First episode genital herpes should be treated with oral acyclovir 200mg five times daily for 5- 10 days. Recurrent genital herpes should be treated with either intermittent oral acyclovir or, in patients with frequent recurrences, long-term suppressive oral acyclovir. Some patients apparently fail to respond to suppressive oral acyclovir. This is usually due to inadequate dose, although resistance to acyclovir may occur in immunosuppressed patients. Phase III clinical trials are now underway to evaluate the efficacy and safety of herpes simplex virus vaccines. (author abstract)
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Genital herpes is one of the commonest sexually transmitted infections. Several antiviral drugs, including acyclovir, famciclovir, and valaciclovir, are now (or will soon be) available for the treatment of genital herpes. First episode genital herpes should be treated with oral acyclovir 200mg five times daily for 5- 10 days. Recurrent genital herpes should be treated with either intermittent oral acyclovir or, in patients with frequent recurrences, long-term suppressive oral acyclovir. Some patients apparently fail to respond to suppressive oral acyclovir. This is usually due to inadequate dose, although resistance to acyclovir may occur in immunosuppressed patients. Phase III clinical trials are now underway to evaluate the efficacy and safety of herpes simplex virus vaccines. (author abstract)
Key concepts: Valaciclovir, Famciclovir, Medicine, Genital herpes, Aciclovir, Herpes Genitalis, Dermatology, Sex organ